DK162630C - Hurtigt oploeselige ensartede laegemiddelpraeparater indeholdende triamteren eller metolazon og fremgangsmaade til fremstilling heraf. - Google Patents

Hurtigt oploeselige ensartede laegemiddelpraeparater indeholdende triamteren eller metolazon og fremgangsmaade til fremstilling heraf.

Info

Publication number
DK162630C
DK162630C DK211084A DK211084A DK162630C DK 162630 C DK162630 C DK 162630C DK 211084 A DK211084 A DK 211084A DK 211084 A DK211084 A DK 211084A DK 162630 C DK162630 C DK 162630C
Authority
DK
Denmark
Prior art keywords
triamter
metolazone
procedures
preparing
preparations containing
Prior art date
Application number
DK211084A
Other languages
Danish (da)
English (en)
Other versions
DK211084A (da
DK162630B (da
DK211084D0 (da
Inventor
Yegnasawami Raghunathan
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of DK211084D0 publication Critical patent/DK211084D0/da
Publication of DK211084A publication Critical patent/DK211084A/da
Publication of DK162630B publication Critical patent/DK162630B/da
Application granted granted Critical
Publication of DK162630C publication Critical patent/DK162630C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DK211084A 1983-04-29 1984-04-27 Hurtigt oploeselige ensartede laegemiddelpraeparater indeholdende triamteren eller metolazon og fremgangsmaade til fremstilling heraf. DK162630C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49005683A 1983-04-29 1983-04-29
US49005683 1983-04-29
US06/586,605 US4517179A (en) 1983-04-29 1984-03-06 Rapid dissolving, uniform drug compositions and their preparation
US58660584 1984-03-06

Publications (4)

Publication Number Publication Date
DK211084D0 DK211084D0 (da) 1984-04-27
DK211084A DK211084A (da) 1984-10-30
DK162630B DK162630B (da) 1991-11-25
DK162630C true DK162630C (da) 1992-04-13

Family

ID=27049920

Family Applications (1)

Application Number Title Priority Date Filing Date
DK211084A DK162630C (da) 1983-04-29 1984-04-27 Hurtigt oploeselige ensartede laegemiddelpraeparater indeholdende triamteren eller metolazon og fremgangsmaade til fremstilling heraf.

Country Status (13)

Country Link
US (1) US4517179A (es)
EP (1) EP0124027B1 (es)
AU (1) AU565640B2 (es)
CA (1) CA1216236A (es)
CH (1) CH662947A5 (es)
DE (1) DE3482402D1 (es)
DK (1) DK162630C (es)
ES (1) ES8602418A1 (es)
FI (1) FI85215C (es)
IE (1) IE57137B1 (es)
IL (1) IL71506A (es)
NZ (1) NZ207678A (es)
PT (1) PT78395B (es)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4721709A (en) * 1984-07-26 1988-01-26 Pyare Seth Novel pharmaceutical compositions containing hydrophobic practically water-insoluble drugs adsorbed on pharmaceutical excipients as carrier; process for their preparation and the use of said compositions
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
US5028633A (en) * 1985-02-21 1991-07-02 Freund Industrial Co., Ltd. Excipient for use in compression molding and process of preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4707361A (en) * 1985-08-02 1987-11-17 Stauffer Chemical Company Granular anhydrous dicalcium phosphate compositions suitable for direct compression tableting
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4677130A (en) * 1985-10-07 1987-06-30 Great Lakes Chemical Corporation Process of densification of N-halohydantoin compositions and products thereof
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
ATE133068T1 (de) * 1991-01-30 1996-02-15 Wellcome Found Wasserlösliche tabletten
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DK0587744T3 (da) * 1991-05-28 2003-10-20 Mcneil Ppc Inc Tygbar sammensætning til frigørelse af et lægemiddel
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE59300688D1 (de) * 1993-05-15 1995-11-02 Boehringer Mannheim Gmbh Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
DK0800384T3 (da) * 1994-12-14 2001-04-17 Enbalt Trading Ltd Pharmaceutiske tabletformuleringer til direkte kompression
DE19530575A1 (de) * 1995-08-19 1997-02-20 Gruenenthal Gmbh Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US6037380A (en) * 1997-04-11 2000-03-14 Fmc Corporation Ultra-fine microcrystalline cellulose compositions and process
AR017512A1 (es) 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
SE9802973D0 (sv) * 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
EP1128817A1 (en) * 1998-10-27 2001-09-05 Biovail Technologies Ltd Microparticles containing peg and/or peg glyceryl esters
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6048874A (en) * 1999-01-26 2000-04-11 Medeva Pharmaceuticals Manufacturing, Inc. Parenteral metolazone formulations
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
US6602523B1 (en) 2000-08-17 2003-08-05 Technology Holding, Llc. Composite material and process for increasing bioavailability and activity of a beneficial agent
US6462022B1 (en) * 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US20040186105A1 (en) * 2002-08-30 2004-09-23 Allenspach Carl T. Pharmaceutical composition exhibiting consistent drug release profile
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
WO2005011695A1 (en) * 2003-07-31 2005-02-10 The Administrators Of The Tulane Educational Fund Method of treating preeclampsia employing metolazone
DK2821067T3 (en) 2003-09-12 2017-12-04 Amgen Inc Quick solution formulation of cinacalcet
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
US20080058408A1 (en) 2006-05-19 2008-03-06 Rogowski Roberta L Low-dose doxepin for treatment of sleep disorders in elderly patients
WO2007142811A2 (en) * 2006-05-19 2007-12-13 Somaxon Pharmaceuticals, Inc. Low dose doxepin formulations, including buccal, sublingual and fastmelt formulations, and uses of the same to treat insomnia
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
US20080145423A1 (en) * 2006-12-14 2008-06-19 Ajmal Ali Khan Chewable tablet and method of formulating
EP1977734A1 (en) * 2007-04-03 2008-10-08 Royal College of Surgeons in Ireland A method of producing fast dissolving tablets
WO2008128115A2 (en) 2007-04-13 2008-10-23 Somaxon Pharmaceuticals, Inc. Low-dose doxepin formulations
EP2262475A1 (en) * 2008-04-01 2010-12-22 Schering-Plough Healthcare Products, Inc. Chewable tablet and method of formulating
TWI461213B (zh) * 2009-11-05 2014-11-21 Fmc Corp 作為藥物賦形劑之微晶纖維素及磷酸鈣之組合物
US11052049B2 (en) * 2019-04-11 2021-07-06 Atoz Pharmaceuticals Pvt Ltd Capsule dosage forms of triamterene, and process of preparation thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3134719A (en) * 1962-04-05 1964-05-26 American Cyanamid Co Calcium phosphates in tablet compressing
US3360518A (en) * 1966-01-03 1967-12-26 Wallace & Tiernan Inc Tetrahydro-halo-sulfamyl quinazolinones
NL6701470A (es) * 1966-02-03 1967-08-04
US3745216A (en) * 1969-12-18 1973-07-10 Smith Kline French Lab Compositions and methods for producing hypotensive activity with imidazo and pyrimido(2,1-b)quinazoline compounds
DE2416903A1 (de) * 1974-04-06 1975-10-09 Bayer Ag Verwendung von schmelzverspruehtem kugelfoermigem phenacetingranulat zur herstellung von tabletten im direkttablettierverfahren
DE2658500C2 (de) * 1976-12-23 1986-10-09 Knoll Ag, 6700 Ludwigshafen Pharmazeutische Präparate mit kardioprotektiver Wirkung
EP0047734A1 (en) * 1980-03-10 1982-03-24 Edward Mendell Co., Inc. Pharmaceutical vehicle composition and process of producing same
DE3012862A1 (de) * 1980-04-02 1981-10-08 Cassella Ag, 6000 Frankfurt Substituierte 1,2,5-oxdiazol-2-oxide als pharmazeutische wirkstoffe, ihre verwendung und sie enthaltende arzneimittel
DE3107933A1 (de) * 1981-03-02 1982-09-16 Cassella Ag, 6000 Frankfurt Substituierte 3-amino-sydnonimine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
DE3482402D1 (de) 1990-07-12
EP0124027B1 (en) 1990-06-06
EP0124027A1 (en) 1984-11-07
FI841696A (fi) 1984-10-30
IL71506A0 (en) 1984-07-31
PT78395B (en) 1986-06-02
DK211084A (da) 1984-10-30
AU565640B2 (en) 1987-09-24
ES531978A0 (es) 1985-12-01
US4517179A (en) 1985-05-14
FI841696A0 (fi) 1984-04-27
CH662947A5 (de) 1987-11-13
AU2643484A (en) 1984-11-01
DK162630B (da) 1991-11-25
IL71506A (en) 1987-09-16
NZ207678A (en) 1986-11-12
DK211084D0 (da) 1984-04-27
IE57137B1 (en) 1992-05-06
IE840735L (en) 1984-10-29
CA1216236A (en) 1987-01-06
FI85215C (fi) 1992-03-25
FI85215B (fi) 1991-12-13
ES8602418A1 (es) 1985-12-01
PT78395A (en) 1984-05-01

Similar Documents

Publication Publication Date Title
DK162630C (da) Hurtigt oploeselige ensartede laegemiddelpraeparater indeholdende triamteren eller metolazon og fremgangsmaade til fremstilling heraf.
DK162445C (da) Pyranopyridiner, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende pyranopyridinerne
NO823603L (no) Stabiliserte insulinpreparater og fremgangsmaate for fremstilling derav.
NO893896D0 (no) Farmasoeytiske formuleringer og fremgangsmaate for fremstilling av disse.
DK493882A (da) Faeldningskiselsyre og fremgangsmaade til fremstilling deraf
DK99382A (da) Dichlorquinolinderivater og fremgangsmaade til fremstilling heraf
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK130182A (da) Antagonister for argininvasopressin og fremgangsmaade til fremstilling heraf
DK160492C (da) Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater
DK431586A (da) Benzimidazolderivater, fremgangsmaade til fremstilling deraf og laegemiddel indeholdende disse
DK160150C (da) Benzothiazinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende samme
NO822671L (no) Farmasoeytisk virksomme forbindelser og fremgangsmaate for deres fremstilling.
DK590383D0 (da) Pyrimidonderivater og fremgangsmade til fremstilling heraf
DK162221C (da) Cinnolinforbindelser, fremgangsmaade til fremstilling deraf og farmaceutiske midler indeholdende forbindelserne
DK102182A (da) Vandfrit antitranspirationsmiddel og fremgangsmaade til fremstilling deraf
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
DK327983D0 (da) Farmaceutiske praeparater og produkter
NO864194D0 (no) Slipekorn og fremgangsmaate til fremstilling derav.
DK634788A (da) 22-deklorteicoplaniner, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende saadanne forbindelser
DE2960506D1 (en) Arylimidazoles, their synthesis and pharmaceutical or veterinary preparations containing them
DK160283C (da) Farmaceutisk iodoforpraeparat samt fremgangsmaade til fremstilling deraf
DK241686A (da) Carboxyalkyldipeptider, fremstilling deraf og farmaceutiske praeparater indeholdende disse
DK424987A (da) Farmaceutisk praeparat til indgivelse gennem huden og fremgangsmaade til dets fremstilling
DK161687D0 (da) Hydroquinolinderivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende disse derivater.
NO893963D0 (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.

Legal Events

Date Code Title Description
PUP Patent expired